John Robert Fraser Duncan

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

QUBIS Ltd (Qubis) is a venture capital firm, subsidiary of Queen's University of Belfast founded in the year 1984. The firm is headquartered in Belfast, Northern Ireland.

Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

CABI Publishing provides publishing services. The company was founded in 1910 and is headquartered in Wallingford, the United Kingdom.

Westfield Contributory Health Scheme Ltd. provides health insurance services. It offers health cash plan, access surgery, wellness programme, and sleep support. The company was founded in 1919 and is headquartered in Sheffield, the United Kingdom.

Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain.

Edinburgh Technology Fund Ltd ( Edinburgh Technology ) is a venture capital firm founded in 1999. The firm is headquartered in Edinburgh.

Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom.

Fargro Ltd. is a horticulture solutions provider that offers supply chain management, energy consumption, automation and infrastructure solutions, as well as design and procurement services. The company is based in Arundel, UK and were founded in 2007. The British company supports growers, nurseries, and garden centers with products ranging from sundries to state-of-the-art automation systems. The CEO is Richard Hopkins.

Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford.

MIP Diagnostic Ltd. develops molecularly imprinted polymers for research purposes, diagnostics and drugs. The company was founded by Sergey Piletsky in 2015 and is headquartered in Leicester, the United Kingdom.

In-Part Publishing Ltd. operates a matchmaking platform for university-industry collaboration. It connects businesses with academics looking for university-industry collaboration, technology transfer and research commercialization partnerships. The company was founded by Patrick Speedie and Robin Knight and is headquartered in Sheffield, the United Kingdom.

Old College Capital (Old College Capital LP) is a venture capital division of the University of Edinburgh, founded in 2011. The firm is headquartered in Scotland.

Manchester Imaging Ltd. develops dental diagnostic software solutions. It operates as a platform technology underpinning an image analysis software portfolio with development applications in several aspects of dental healthcare. The company was founded by Jim Graham and Hugh Devlin and is headquartered in Manchester, the United Kingdom.

Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom.

Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom.

Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom.

Cytomos Ltd. provides rapid label-free cell analysis for biotechnology research and in-vitro diagnostics using dielectric spectroscopy. The firm offers ePad technology which permits detection, identification, and characterization of single cells in real-time as they progress through an experiment. The company was founded by Keith Muir and is headquartered in Edinburgh, the United Kingdom.

Invizius Ltd. develops application for dialysis patients. It offers hemo compatibility for dialyzers. The company was founded by Andrew Herbert on January 26, 2018 and is headquartered in Edinburgh, the United Kingdom.

Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom.

Oskare Capital SAS is an Independent firm. Oskare Capital SAS is headquartered in Paris, France.

Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell.